Based on these data, we designed a study aimed at identifying the role of cancer-derived HMGB1 in the immune contexture of the TME, with particular focus on B cells, which could potentiate the tumorigenicity of ESCC through angiogenesis. Here, HMGB1 is linked to cancer.